C. Wüster

B. Bengtsson, U. Feldt-Rasmussen, C. Wüster, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Endocrine function and bone metabolism 5 years after autologous bone marrow/blood‐derived progenitor cell transplantation

C. Scheibenbogen, C. Wüster, U. Keilholz, 1997 .

Weight-/height-related bone mineral density is not reduced after renal transplantation

K. Schärer, O. Mehls, C. Wüster, 1998, Pediatric Nephrology.

Bone mass reduction after estrogen deprivation by long-acting gonadotropin-releasing hormone agonists and its relation to pretreatment serum concentrations of 1,25-dihydroxyvitamin D3.

R. Ziegler, S. Scharla, H. Minne, 1990, The Journal of clinical endocrinology and metabolism.

Evolving Therapies: PTH, IGF, GH, Ipriflavone

C. Wüster, 2000 .

Lower serum 25-hydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females: a population-based study.

M. Seibel, R. Ziegler, C. Scheidt-Nave, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

A study of complaints and their relation to vertebral destruction in patients with osteoporosis.

R. Ziegler, F. Raue, P. Sauer, 1990, Bone and mineral.

Outcome of bone mineral density in anorexia nervosa patients 11.7 years after first admission

W. Herzog, R. Ziegler, D. Schellberg, 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Superior local tolerability of human versus salmon calcitonin preparations in young healthy volunteers

R. Ziegler, F. Raue, S. Scharla, 2004, European Journal of Clinical Pharmacology.

The use of quantitative ultrasonometry in patients with glucocorticoid-induced osteoporosis.

C. Wüster, 2002, Frontiers of hormone research.

Measurement of Forearm Bone Mineral Density: Comparison of Precision of Five Different Instruments

M. Götz, R. Ziegler, C. Wüster, 1998, Calcified Tissue International.

Influence of GH substitution therapy in deficient adults on the recurrence rate of hormonally inactive pituitary adenomas: a case control study.

G. Brabant, M. Buchfelder, A. Kleindienst, 2007, European journal of endocrinology.

The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.

B. Bengtsson, U. Feldt-Rasmussen, C. Wüster, 1999, The Journal of clinical endocrinology and metabolism.

Leptin—a parameter for body fat measurement in patients with eating disorders

J. Hebebrand, M. Hartmann, S. Zipfel, 1998 .

Ultrasound transmission speed and ultrasound bone profile score (UBPS) of the phalanges in normal women and women with osteoporosis.

R. Ziegler, C. Wüster, R. Cadossi, 1998, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Assessment by quantitative ultrasonometry of the effects of hormone replacement therapy on bone mass.

G. Emons, C. Wüster, P. Hadji, 2000, American journal of obstetrics and gynecology.

Growth hormone deficiency and replacement in elderly hypopituitary adults

M. Thorén, B. Bengtsson, C. Wüster, 2000, Clinical endocrinology.

Benefits of growth hormone treatment on bone metabolism, bone density and bone strength in growth hormone deficiency and osteoporosis.

R. Ziegler, C. Wüster, U. Rehn, 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Growth hormone and bone metabolism.

C. Wüster, 1993, Acta endocrinologica.

Effects of GnRH Agonist-Induced Ovarian Suppression on Calcium Homeostasis and Bone Metabolism in Premenstrual Women

R. Ziegler, S. Scharla, H. Minne, 1990 .

[Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: need for additional growth hormone substitution?].

R. Ziegler, C. Wüster, Reinhard Ziegler, 1991, Klinische Wochenschrift.

Reduced bone mineral density and low parathyroid hormone levels in patients with the adult form of hypophosphatasia

R. Ziegler, C. Wüster, 1992, The clinical investigator.

Bone disease after liver transplantation.

B. Kommerell, G. Otto, L. Theilmann, 1992, Transplantation proceedings.

Performance and Specificity of 6 Immunoassays for TSH Receptor Antibodies: A Multicenter Study

P. D. Olivo, G. Kahaly, B. Decallonne, 2017, European Thyroid Journal.

Highly variable sensitivity of five binding and two bio-assays for TSH-receptor antibodies

G. Kahaly, C. Wüster, T. Diana, 2016, Journal of Endocrinological Investigation.

Magnetic Resonance Imaging after Transsphenoidal Surgery of Clinically Non-Functional Pituitary Macroadenomas and its Impact on Detecting Residual Adenoma

K. Sartor, M. Forsting, S. Kunze, 2002, Acta Neurochirurgica.

Consensus Statement on the Use of Bone Turnover Markers for Short-Term Monitoring of Osteoporosis Treatment in the Asia-Pacific Region.

C. Cooper, I. Reid, A. Mithal, 2019, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Increased Incidence of Euthyroid and Hyperthyroid Goiters Independently of Thyrotropin in Patients with Acromegaly

R. Ziegler, G. Steger, H. Minne, 1991, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Methylpentylaminopropylidenebisphosphonate (BM 21.0955): a new potent and safe bisphosphonate for the treatment of cancer-associated hypercalcemia.

M. Ghielmini, D. Thiebaud, S. Scharla, 1993, Bone and mineral.

Chapter 78 – Growth Hormone, Insulin-like Growth Factors: Potential Applications and Limitations in the Management of Osteoporosis

C. Rosen, C. Wüster, 2001 .

[Vertebral deformity as an index of osteoporosis-induced spinal fracture--an external validity construct based on bone density data].

D. Felsenberg, R. Ziegler, C. Scheidt-Nave, 1998, Medizinische Klinik.

Ultrasound velocity of the tibia in normal german women and hip fracture patients

R. Ziegler, C. Wüster, M. Götz, 1996, Calcified Tissue International.

Use of Quantitative Ultrasound Densitometry (QUS) in Male Osteoporosis

C. Wüster, P. Hadji, 2001, Calcified Tissue International.

Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease.

B. Bengtsson, M. Bramnert, C. Wüster, 2002, European journal of endocrinology.

Comparison of a Novel Homogeneous Cyclic Amp Assay and a Luciferase Assay for Measuring Stimulating Thyrotropin-Receptor Autoantibodies

P. D. Olivo, G. Kahaly, Yie-Hwa Chang, 2019, European Thyroid Journal.

Fracture Rates in Patients with Growth Hormone Deficiency

C. Wüster, 2000, Hormone Research in Paediatrics.

Growth hormone replacement therapy is not associated with any increase in mortality. KIMS Study Group.

B. Bengtsson, H. Koppeschaar, U. Feldt-Rasmussen, 1999, The Journal of clinical endocrinology and metabolism.

High Titers of Thyrotropin Receptor Antibodies Are Associated With Orbitopathy in Patients With Graves Disease.

P. D. Olivo, G. Kahaly, C. Wüster, 2019, The Journal of clinical endocrinology and metabolism.

The Female Climacteric

C. Wüster, T. Rabe, T. Holst, 1997 .

Can growth hormone therapy cause diabetes?

B. Bengtsson, B. Bengtsson, U. Feldt-Rasmussen, 2000, The Lancet.

Can growth hormone therapy cause diabetes? KIMS Strategic Committee.

B. Bengtsson, U. Feldt-Rasmussen, C. Wüster, 2000, The Lancet.

Serum Insulin-Like Growth Factor I Reference Values for an Automated Chemiluminescence Immunoassay System: Results from a Multicenter Study

G. Brabant, L. Wilhelmsen, M. Ranke, 2003, Hormone Research in Paediatrics.

A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine /collagen content in a long-term Graves' disease mouse model.

G. Kahaly, C. Wüster, A. Reimann, 2021, Journal of autoimmunity.

Hypergonadotropic hypogonadism in a patient with inv ins (2;4).

V. Kalscheuer, A. Tzschach, C. Menzel, 2009, International journal of andrology.

Long-term excess of endogenous calcitonin in patients with medullary thyroid carcinoma does not affect bone mineral density.

R. Ziegler, F. Raue, C. Wüster, 1992, The Journal of endocrinology.

Endoscopic endonasal pituitary surgery: Surgical and outcome analysis of 50 cases

C. Wüster, A. Perneczky, R. Reisch, 2007, Journal of Clinical Neuroscience.

Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10

Martin Fassnacht, Marta Barontini, Gabriela Sanso, 2011, Human mutation.

A Novel Long-Term Graves’ Disease Animal Model Confirmed by Functional Thyrotropin Receptor Antibodies

G. Kahaly, C. Wüster, M. Ungerer, 2020, European Thyroid Journal.

Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation.

C. Scheibenbogen, C. Wüster, U. Keilholz, 1997, Cancer.

Binostril versus mononostril approaches in endoscopic transsphenoidal pituitary surgery: clinical evaluation and cadaver study.

A. Giese, J. Oertel, C. Wüster, 2016, Journal of neurosurgery.

No advantage of the new combined octreotide‐GHRH test over established GH‐stimulation tests in the diagnosis of growth hormone deficiency (GHD) in adults

R. Ziegler, C. Wüster, P. Hadji, 2000, Clinical endocrinology.

Serum levels of intact parathyroid hormone and alkaline phosphatase correlate with cortical and trabecular bone loss in primary hyperparathyroidism.

R. Ziegler, J. Pfeilschifter, C. Wüster, 1992, Acta endocrinologica.

A newly developed spine deformity index (SDI) to quantitate vertebral crush fractures in patients with osteoporosis.

R. Ziegler, P. Sauer, G. Leidig, 1988, Bone and mineral.

Phalangeal Osteosonogrammetry Study: Age‐Related Changes, Diagnostic Sensitivity, and Discrimination Power

J. Reginster, C. Albanese, D. Hans, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Quantitative ultrasound (QUS) of bone in the management of postmenopausal women.

C. Wüster, P. Hadji, M. Gambacciani, 2004, Maturitas.

Bone mass of spine and forearm in osteoporosis and in German normals: influences of sex, age and anthropometric parameters

G. Duckeck, R. Ziegler, H. Minne, 1992, European journal of clinical investigation.

Stiffness index identifies patients with osteoporotic fractures better than ultrasound velocity or attenuation alone.

G. Emons, C. Wüster, P. Hadji, 1999, Maturitas.

Inflammation-mediated osteopenia (IMO) during acute inflammation in rats is due to a transient inhibition of bone formation

R. Ziegler, J. Pfeilschifter, H. Minne, 1987, Calcified Tissue International.

Sex Difference in the Validity of Vertebral Deformities as an Index of Prevalent Vertebral Osteoporotic Fractures: A Population Survey of Older Men and Women

D. Felsenberg, B. Limberg, R. Ziegler, 2000, Osteoporosis International.

Levels of Parathyroid Hormone-Related Protein (PTHrP) in Hypercalcemia of Malignancy Are not Lowered by Treatment With the Bisphosphonate BM 21.0955

R. Ziegler, F. Raue, C. Wüster, 1993, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Usefulness of quantitative ultrasound in evaluating structural and mechanical properties of bone: comparison of ultrasound, dual-energy X-ray absorptiometry, micro-computed tomography, and mechanical testing of human phalanges in vitro.

R. Müller, F. Terlizzi, C. Wüster, 2005, Technology and health care : official journal of the European Society for Engineering and Medicine.

Ultrasound Measurements at the Proximal Phalanges in Healthy Women and Patients with Hip Fractures

R. Ziegler, C. Wüster, P. Meeder, 1998, Osteoporosis International.

Decreased insulin-like growth factors 1 and 2 in sera of patients with osteoporosis

M. Ranke, R. Ziegler, W. Blum, 1992 .

Comparison of dual-energy X-ray absorptiometry with six quantitative ultrasonometry devices in women with hip fractures

C. Wüster, U. Albert, P. Hadji, 2015, Climacteric : the journal of the International Menopause Society.

Assessment of Bone Architecture with Ultrasonometry: Experimental and Clinical Experience

Milena Fini, Ruggero Cadossi, C. Wüster, 2004, Hormone Research in Paediatrics.

Use of quantitative ultrasound densitometry in male osteoporosis: diagnosis and treatment

C. Wüster, P. Hadji, 1999 .

Inter-laboratory comparison of IGF-I concentrations measured by an automated immunoassay: Results from a multicentre study across Europe

M. Bidlingmaier, J. Kratzsch, J. Frystyk, 2015 .

Quantitative ultrasonometry (QUS) for the evaluation of osteoporosis risk: reference data for various measurement sites, limitations and application possibilities.

C. Wüster, J. Schlegel, J. Pereira-Lima, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Growth Hormone, Insulin-like Growth Factors

C. Rosen, C. Wüster, 2001 .

Image-guided endonasal transsphenoidal microsurgical treatment of recurrent microadenomas of the pituitary gland.

C. Wüster, R. Reisch, P. Charalampaki, 2006, Minimally invasive neurosurgery : MIN.

Growth Hormone and Bone: Clinical Outcomes of Growth Hormone Replacement Therapy

C. Wüster, 2000 .

[Multiple endocrine neoplasia associated with multiple lipomas].

M. Brandi, T. Schilling, R. Ziegler, 1998, Medizinische Klinik.